Patent · US Active

PD-1 binding proteins and methods of use thereof

US10428145B2 · kind B2 · utility

8Cited by

127References

155Claims

0Family size

Assignee

CELGENE CORPORATION · US

Inventors

Brydon L. Bennett · San Diego, US
Philip Chamberlain · San Diego, US
Kandasamy Hariharan · San Diego, US
Pilgrim Jackson · San Diego, US
Marilyn Kehry · San Diego, US
Roli Khattri · Kirkland, US
Monica Wai Ling Leung · Summit, US
Lisa Morrison · San Diego, US
Jeonghoon Sun · Thousand Oaks, US
Sanaa Torres · San Marcos, US
Henry Hin Lee Chan

Key dates

Filing date	Sep 28, 2016
Grant date	Oct 1, 2019
Priority date	—
Expiry date	Oct 20, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.